{
    "title": "ADMarker: A Multi-Modal Federated Learning System for Monitoring Digital Biomarkers of Alzheimer's Disease. (arXiv:2310.15301v1 [cs.LG])",
    "abstract": "Alzheimer's Disease (AD) and related dementia are a growing global health challenge due to the aging population. In this paper, we present ADMarker, the first end-to-end system that integrates multi-modal sensors and new federated learning algorithms for detecting multidimensional AD digital biomarkers in natural living environments. ADMarker features a novel three-stage multi-modal federated learning architecture that can accurately detect digital biomarkers in a privacy-preserving manner. Our approach collectively addresses several major real-world challenges, such as limited data labels, data heterogeneity, and limited computing resources. We built a compact multi-modality hardware system and deployed it in a four-week clinical trial involving 91 elderly participants. The results indicate that ADMarker can accurately detect a comprehensive set of digital biomarkers with up to 93.8% accuracy and identify early AD with an average of 88.9% accuracy. ADMarker offers a new platform that ",
    "link": "http://arxiv.org/abs/2310.15301",
    "context": "Title: ADMarker: A Multi-Modal Federated Learning System for Monitoring Digital Biomarkers of Alzheimer's Disease. (arXiv:2310.15301v1 [cs.LG])\nAbstract: Alzheimer's Disease (AD) and related dementia are a growing global health challenge due to the aging population. In this paper, we present ADMarker, the first end-to-end system that integrates multi-modal sensors and new federated learning algorithms for detecting multidimensional AD digital biomarkers in natural living environments. ADMarker features a novel three-stage multi-modal federated learning architecture that can accurately detect digital biomarkers in a privacy-preserving manner. Our approach collectively addresses several major real-world challenges, such as limited data labels, data heterogeneity, and limited computing resources. We built a compact multi-modality hardware system and deployed it in a four-week clinical trial involving 91 elderly participants. The results indicate that ADMarker can accurately detect a comprehensive set of digital biomarkers with up to 93.8% accuracy and identify early AD with an average of 88.9% accuracy. ADMarker offers a new platform that ",
    "path": "papers/23/10/2310.15301.json",
    "total_tokens": 1015,
    "translated_title": "ADMarker: 一种多模式联邦学习系统，用于监测阿尔茨海默病的数字生物标志物",
    "translated_abstract": "阿尔茨海默病（AD）及相关痴呆症由于人口老龄化而成为全球日益严重的健康挑战。本文介绍了ADMarker，这是第一个将多模式传感器和新的联邦学习算法整合起来，以在自然生活环境中检测多维AD数字生物标志物的端到端系统。ADMarker具有一种新颖的三阶段多模式联邦学习架构，能够以保护隐私的方式准确检测数字生物标志物。我们的方法共同解决了数据标签有限、数据异质性和有限的计算资源等几个主要的现实世界挑战。我们建立了一个紧凑的多模式硬件系统，并在一个为期四周的临床试验中将其部署在91名老年参与者身上。结果表明，ADMarker能够准确检测出全面的数字生物标志物，准确率高达93.8％，并以平均88.9％的准确率识别出早期AD。ADMarker提供了一个新的平台，可以在监测AD患者时提供准确和高效的数据分析。",
    "tldr": "ADMarker是一个多模式联邦学习系统，用于在自然生活环境中监测阿尔茨海默病的数字生物标志物。它具有新颖的联邦学习架构，能够准确检测出数字生物标志物，并在临床试验中展示出高准确率和早期AD识别能力。",
    "en_tdlr": "ADMarker is a multi-modal federated learning system for monitoring digital biomarkers of Alzheimer's Disease in natural living environments. It features a novel federated learning architecture that accurately detects digital biomarkers and has shown high accuracy and early AD identification capability in clinical trials."
}